The Imperative Trial: Treatment of Acute Ischemic Stroke With the Zoom Reperfusion System

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 328 participants.

Also called NCT04129125

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 328 participants (enrolled count) (from the registry)
Sponsor
Imperative Care, Inc. (from the registry)
Registry
  • NCT NCT04129125
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
United States (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT04129125. Allocation not applicable; no masking; primary purpose treatment. Start 2021-10-01 (actual); primary completion 2024-05-28 (actual). Results posted on 2025-08-08.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
The Imperative Trial: Treatment of Acute Ischemic Stroke With the Zoom Reperfusion System
Condition
Acute Stroke
Intervention (Device)
Zoom Reperfusion System
Lead sponsor
Imperative Care, Inc. (class: industry)

Record details

Record id
cardio:ct-nct04129125
Content hash
2463f5d0f8c95b6cb868e07575f5b69938574f36a2ed083be5a3d8dbdf617af6